{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,23]],"date-time":"2022-04-23T06:06:14Z","timestamp":1650693974275},"reference-count":51,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2018,11,30]]},"DOI":"10.1536\/ihj.17-583","type":"journal-article","created":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T22:37:32Z","timestamp":1540420652000},"page":"1202-1210","source":"Crossref","is-referenced-by-count":2,"title":["Comparison of Limus-Eluting and Paclitaxel-Eluting Stents for Coronary Intervention in Patients with Chronic Kidney Disease"],"prefix":"10.1536","volume":"59","author":[{"given":"Xiuhui","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Hypertension, Luohe Central Hospital, The First Affiliated Hospital of Luohe Medical College"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingquan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Hypertension, Luohe Central Hospital, The First Affiliated Hospital of Luohe Medical College"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijun","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of Hypertension, Luohe Central Hospital, The First Affiliated Hospital of Luohe Medical College"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haoran","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hypertension, Luohe Central Hospital, The First Affiliated Hospital of Luohe Medical College"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiaotao","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Hypertension, Luohe Central Hospital, The First Affiliated Hospital of Luohe Medical College"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Best PJ, Lennon R, Ting HH, <i>et al<\/i>. The impact of renal insuf\ufb01ciency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol 2002; 39: 1113-9.","DOI":"10.1016\/S0735-1097(02)01745-X"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Nakazawa G, Tanabe K, Aoki J, <i>et al<\/i>. Impact of renal insufficiency on clinical and angiographic outcomes following percutaneous coronary intervention with sirolimus-eluting stents. Catheter Cardiovasc Interv 2007; 69: 808-14.","DOI":"10.1002\/ccd.21016"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Naidu SS, Selzer F, Jacobs A, <i>et al<\/i>. Renal insufficiency is an independent predictor of mortality after percutaneous coronary intervention. Am J Cardiol 2003; 92: 1160-4.","DOI":"10.1016\/j.amjcard.2003.07.023"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Murata N, Kaneko H, Yajima J, <i>et al<\/i>. The prognostic impact of worsening renal function in Japanese patients undergoing percutaneous coronary intervention with acute coronary syndrome. J Cardiol 2015; 66: 326-32.","DOI":"10.1016\/j.jjcc.2014.12.005"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Naidu SS, Selzer F, Jacobs A, <i>et al<\/i>. Renal insufficiency is an independent predictor of mortality after percutaneous coronary intervention. Am J Cardiol 2003; 92: 1160-4.","DOI":"10.1016\/j.amjcard.2003.07.023"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Yachi S, Tanabe K, Tanimoto S, <i>et al<\/i>. Clinical and angiographic outcomes following percutaneous coronary intervention with sirolimus-eluting stents versus bare-metal stents in hemodialysis patients. Am J Kidney Dis 2009; 54: 299-306.","DOI":"10.1053\/j.ajkd.2009.01.263"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Shenoy C, Boura J, Orshaw P, Harjai KJ. Drug-eluting stents in patients with chronic kidney disease: A prospective registry study. PLoS One 2010; 5: e15070.","DOI":"10.1371\/journal.pone.0015070"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Barthelemy O, Helft G, Silvain J, <i>et al<\/i>. One-year clinical outcomes in patients with chronic renal failure treated by percutaneous coronary intervention with drug-eluting stent. Arch Cardiovasc Dis 2011; 104: 604-10.","DOI":"10.1016\/j.acvd.2011.05.010"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Ann SH, Seo SM, Kim PJ, <i>et al<\/i>. Sirolimus-eluting stent is superior to paclitaxel-eluting stent for coronary intervention in patients with renal insufficiency: Long-term clinical outcomes. Cardiol J 2016; 23: 637-46.","DOI":"10.5603\/CJ.a2016.0065"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Otsuka M, Yokoi H, Matsuyama Y, <i>et al<\/i>. Comparison of sirolimus- and paclitaxel-eluting stents in patients with moderate renal insufficiency: results from the J-DESsERT trial. Cardiovasc Revasc Med 2014; 15: 323-8.","DOI":"10.1016\/j.carrev.2014.09.003"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Kamoi D, Ishii H, Takahashi H, <i>et al<\/i>. Sirolimus- vs. paclitaxel-eluting stent to coronary intervention in dialysis patients. Int J Cardiol 2013; 165: 533-6.","DOI":"10.1016\/j.ijcard.2011.09.078"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Simsek C, Magro M, Boersma E, <i>et al<\/i>. Impact of renal insufficiency on safety and efficacy of drug-eluting stents compared to bare-metal stents at 6 years. Catheter Cardiovasc Interv 2012; 80: 18-26.","DOI":"10.1002\/ccd.23199"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Hamilos M, Sarma J, Ostojic M, <i>et al<\/i>. Interference of drug-eluting stents with endothelium-dependent coronary vasomotion: evidence for device-specific responses. Circ Cardiovasc Interv 2008; 1: 193-200.","DOI":"10.1161\/CIRCINTERVENTIONS.108.797928"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Minami Y, Kaneda H, Inoue M, <i>et al<\/i>. Endothelial dysfunction following drug-eluting stent implantation: a systematic review of the literature. Int J Cardiol 2013; 165: 222-8.","DOI":"10.1016\/j.ijcard.2012.03.084"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Crimi G, Leonardi S, Costa F, <i>et al<\/i>. Role of stent type and of duration of dual antiplatelet therapy in patients with chronic kidney disease undergoing percutaneous coronary interventions. Is bare metal stent implantation still a justifiable choice? A post-hoc analysis of the all comer PRODIGY trial. Int J Cardiol 2016; 212: 110-7.","DOI":"10.1016\/j.ijcard.2016.03.033"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Otsuka M, Shiode N, Masaoka Y, <i>et al<\/i>. Comparison of everolimus- and paclitaxel-eluting stents in dialysis patients. Cardiovasc Revasc Med 2015; 16: 208-12.","DOI":"10.1016\/j.carrev.2015.04.005"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Hachinohe D, Jeong MH, Saito S, <i>et al<\/i>. Comparison of drug-eluting stents in acute myocardial infarction patients with chronic kidney disease. Korean J Intern Med 2012; 27: 397-406.","DOI":"10.3904\/kjim.2012.27.4.397"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Liberati A, Altman DG, Tetzlaff J, <i>et al<\/i>. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 2009; 62: e1-e34.","DOI":"10.1016\/j.jclinepi.2009.06.006"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Jadad AR, Moore RA, Carroll D, <i>et al<\/i>. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 1-12.","DOI":"10.1016\/0197-2456(95)00134-4"},{"key":"20","unstructured":"20. Wells GA, Shea B, O&apos;Connell D, <i>et al<\/i>. The Newcastle-Ottawa scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses. Ottawa: Dept of Epidemiology and Community Medicine, University of Ottawa. Accessed January, 2017. Available at: http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.htm.2011."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-88.","DOI":"10.1016\/0197-2456(86)90046-2"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-34.","DOI":"10.1136\/bmj.315.7109.629"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Kitasato L, Shimohama T, Ikeda Y, <i>et al<\/i>. Clinical outcomes of chronic kidney disease patients treated with everolimus-eluting stents (EES) and paclitaxel-eluting stents (PES). Biomed Pharmacother 2015; 72: 6-10.","DOI":"10.1016\/j.biopha.2015.03.002"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Sardi GL, Loh JP, Torguson R, <i>et al<\/i>. Drug-eluting stents in patients on chronic hemodialysis: paclitaxel-eluting stents vs. limus-eluting stents. Cardiovasc Revasc Med 2014; 15: 86-91.","DOI":"10.1016\/j.carrev.2014.01.006"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Yano H, Horinaka S, Yagi H, Ishimitsu T. Comparison of inflammatory response after implantation of sirolimus- and paclitaxel-eluting stents in patients on hemodialysis. Heart Vessels 2013; 28: 308-15.","DOI":"10.1007\/s00380-012-0250-9"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Tsujita H, Hamazaki Y, Nishikura T, <i>et al<\/i>. Sirolimus-eluting stents versus paclitaxel-eluting stents for coronary intervention in patients with renal failure on hemodialysis. Cardiovasc Interv Ther 2013; 28: 9-15.","DOI":"10.1007\/s12928-012-0103-6"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Ahmed K, Jeong MH, Chakraborty R, <i>et al<\/i>. Coronary Stents in Patients with ST-Elevation Myocardial Infarction and Chronic Kidney Disease Undergoing Primary Percutaneous Coronary Intervention. Korean Circ J 2012; 42: 830-8.","DOI":"10.4070\/kcj.2012.42.12.830"},{"key":"28","doi-asserted-by":"publisher","unstructured":"28. Otsuka M, Toyofuku M, Watanabe N, <i>et al<\/i>. Clinical usefulness of drug-eluting stents in the treatment of dialysis patients with coronary artery disease. EuroIntervention 2011; 6: 754-9.","DOI":"10.4244\/EIJV6I6A128"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Higashitani M, Mori F, Yamada N, <i>et al<\/i>. Efficacy of paclitaxel-eluting stent implantation in hemodialysis patients. Heart Vessels 2011; 26: 582-9.","DOI":"10.1007\/s00380-010-0110-4"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Sukhija R, Aronow WS, Palaniswamy C, <i>et al<\/i>. Major adverse cardiac events in patients with moderate to severe renal insufficiency treated with first-generation drug-eluting stents. Am J Cardiol 2010; 105: 293-6.","DOI":"10.1016\/j.amjcard.2009.09.031"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Syed AI, Ben-Dor I, Collins SD, <i>et al<\/i>. Sirolimus-eluting stents versus paclitaxel-eluting stents in patients with chronic renal insufficiency. J Interv Cardiol 2010; 23: 33-9.","DOI":"10.1111\/j.1540-8183.2009.00524.x"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Jeong YH, Hong MK, Lee CW, <i>et al<\/i>. Impact of significant chronic kidney disease on long-term clinical outcomes after drug-eluting stent versus bare metal stent implantation. Int J Cardiol 2008; 125: 36-40.","DOI":"10.1016\/j.ijcard.2007.02.026"},{"key":"33","doi-asserted-by":"publisher","unstructured":"33. Schiffrin EL, Lipman ML, Mann JF. Chronic kidney disease: effects on the cardiovascular system. Circulation 2007; 116: 85-97.","DOI":"10.1161\/CIRCULATIONAHA.106.678342"},{"key":"34","doi-asserted-by":"publisher","unstructured":"34. Rubenstein MH, Harrell LC, Sheynberg BV, <i>et al<\/i>. Are patients with renal failure good candidates for percutaneous coronary revascularization in the new device era. Circulation 2000; 102: 2966-72.","DOI":"10.1161\/01.CIR.102.24.2966"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Keeley EC, Kadakia R, Soman S, <i>et al<\/i>. Analysis of long-term survival after revascularization in patients with chronic kidney disease presenting with acute coronary syndromes. Am J Cardiol 2003; 92: 509-14.","DOI":"10.1016\/S0002-9149(03)00716-1"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Uchida Y, Ichimiya S, Ishii H, <i>et al<\/i>. Impact of coronary stent fracture on restenotic neointimal tissue characterization after drug-eluting stent implantation. Int Heart J 2017; 58: 861-7.","DOI":"10.1536\/ihj.16-571"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Oba Y, Hoshide S, Mitama T, <i>et al<\/i>. Recurrent early coronary stent thrombosis under chronic disseminated intravascular coagulation. Int Heart J 2017; 58: 988-92.","DOI":"10.1536\/ihj.17-010"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Suzuki K, Ishikawa T, Mutoh M, <i>et al<\/i>. Propensity-score matched comparison of midterm angiographic outcomes of sirolimus- versus everolimus- and biolimus-eluting stents for de novo coronary stenosis. Int Heart J 2017; 58: 320-7.","DOI":"10.1536\/ihj.16-360"},{"key":"39","doi-asserted-by":"publisher","unstructured":"39. Jensen LO, Thayssen P, Hansen HS, <i>et al<\/i>. Randomized comparison of everolimus-eluting and sirolimus-eluting stents in patients treated with percutaneous coronary intervention: the Scandinavian Organization for Randomized Trials with Clinical Outcome IV (SORT OUT IV). Circulation 2012; 125: 1246-55.","DOI":"10.1161\/CIRCULATIONAHA.111.063644"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Camenzind E, Wijns W, Mauri L, <i>et al<\/i>. Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised, multicentre, open-label, controlled trial. Lancet 2012; 380: 1396-405.","DOI":"10.1016\/S0140-6736(12)61336-1"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Leon MB, Nikolsky E, Cutlip DE, <i>et al<\/i>. Improved late clinical safety with zotarolimus-eluting stents compared with paclitaxel-eluting stents in patients with de novo coronary lesions: 3-year follow-up from the ENDEAVOR IV (Randomized Comparison of Zotarolimus- and Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease) trial. JACC Cardiovasc Interv 2010; 3: 1043-50.","DOI":"10.1016\/j.jcin.2010.07.008"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Doostzadeh J, Clark LN, Bezenek S, <i>et al<\/i>. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCEV drug-eluting stent. Coron Artery Dis 2010; 21: 46-56.","DOI":"10.1097\/MCA.0b013e328333f550"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Hamilos M, Sarma J, Ostojic M, <i>et al<\/i>. Interference of drug-eluting stents with endothelium-dependent coronary vasomotion: evidence for device-specific responses. Circ Cardiovasc Interv 2008; 1: 193-200.","DOI":"10.1161\/CIRCINTERVENTIONS.108.797928"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Okura H, Nakamura M, Kotani J, Kozuma K. Gender-specific outcome after paclitaxel-eluting stent implantation in Japanese patients with coronary artery disease - sub-analysis of the Japan TAXUS Express2 post-marketing survey. Circ J 2013; 77: 1430-5.","DOI":"10.1253\/circj.CJ-12-0678"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Kuchulakanti PK, Torguson R, Chu WW, <i>et al<\/i>. Impact of chronic renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary intervention with sirolimus-eluting stents versus bare metal stents. Am J Cardiol 2006; 97: 792-7.","DOI":"10.1016\/j.amjcard.2005.10.018"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Ota T, Umeda H, Yokota S, <i>et al<\/i>. Relationship between severity of renal impairment and 2-year outcomes after sirolimus-eluting stent implantation. Am Heart J 2009; 158: 92-8.","DOI":"10.1016\/j.ahj.2009.04.013"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Jung HH, Kim SW, Han H. In\ufb02ammation, mineral metabolism and progressive coronary artery calcification in patients on haemodialysis. Nephrol Dial Transplant 2006; 21: 1915-20.","DOI":"10.1093\/ndt\/gfl118"},{"key":"48","doi-asserted-by":"publisher","unstructured":"48. Herzog CA, Ma JZ, Collins AJ. Comparative survival of dialysis patients in the United States after coronary angioplasty, coronary artery stenting, and coronary artery bypass surgery and impact of diabetes. Circulation 2002; 106: 2207-11.","DOI":"10.1161\/01.CIR.0000035248.71165.EB"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Naidu SS, Selzer F, Jacobs A, <i>et al<\/i>. Renal insufficiency is an independent predictor of mortality after percutaneous coronary intervention. Am J Cardiol 2003; 92: 1160-4.","DOI":"10.1016\/j.amjcard.2003.07.023"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Ikari Y, Tanabe K, Koyama Y, <i>et al<\/i>. Sirolimus eluting coronary stent implantation in patients on maintenance hemodialysis: the OUCH study (outcome of cypher stent inhemodialysis patients). Circ J 2012; 76: 1856-63.","DOI":"10.1253\/circj.CJ-12-0046"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Nakazawa G, Tanabe K, Aoki J, <i>et al<\/i>. Impact of renal insufficiency on clinical and angiographic outcomes following percutaneous coronary intervention with sirolimus-eluting stents. Catheter Cardiovasc Interv 2007; 69: 808-14.","DOI":"10.1002\/ccd.21016"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/59\/6\/59_17-583\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T05:01:22Z","timestamp":1543640482000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/59\/6\/59_17-583\/_article"}},"subtitle":["A Meta-Analysis"],"short-title":[],"issued":{"date-parts":[[2018,11,30]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.17-583","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,30]]}}}